Cirugía en medicina general: manual de enfermedades quirúrgicas

297 Capítulo 27 / Tumores Hepáticos Malignos 698. Nguyen, K., Gamblin, T., & Geller, D. (2009). World review of laparoscopic liver resection-2,804 patients. Annals of surgery, 831-841. Norero, E., Jarufe, N., Butte, J., Norero, B., Duarte, I., Torres, J., . . . Martínez, J. (2009). Resultados del tratamiento quirúrgico de las metástasis hepáticas por cáncer colorrectal. Revista médica de Chile, 487-496. Poon, R., Fan, S., Tsang, F., & Wong, J. (2002). Locorregional therapies for hepatocellular carcinoma: a critical review from the surgeon perspective. Annals of surgery, 466-486. Razumilava, N., & Gores, G. (2014). Cholangiocarcinoma. Lancet, 2168-2179. Schnitzbauer, A., Lang, S., Goessmann, H., Nadalin, S., Baumgart, J., Farkas, S., . . . Schlitt, H. (2012). Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Annals of surgery, 405-414. Senra, L., Andara, M., & Noa, G. (2015). Metástasis hepática como forma de presentación de cáncer. Revista cubana de medicina, 27-39. Seogsong, J., & Meng, S. (2017). Current status of liver transplantation for cholangiocarcinoma. Liver transplantation. Shady, W., Petre, E., Gonen, M., Erinjeri, J., Brown, K., Covey, A., . . . C, S. (2016). Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center. Radiology, 601-611. Shindoh, J. (2017). Ablative therapies for intrahepatic cholangiocarcinoma. Hepatobiliary surgery and nutrition, 2-6. Sommer, C., Kauczor, H., & Pereira, P. (2016). Locoregional Therapies of Cholangiocarcinoma. Visceral medicine, 414-420. Taniguchi, M., Kim, S., Imoto, S., Ikawa, H., Ando, K., Mita, K., . . . Hayashi, Y. (2008). Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma. World journal of gastroenterology, 1997-2002. Toso, C., Trotter, J., Wei, A., Bigam, D., Shah, S., Lancaster, J., . . . Kneteman, N. (2008). Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transplantation, 1107-1115. Weber, S., Ribero, D., O'Reilly, E., Kokudo, N., Miyazaki, M., & T., P. (2015). Intrahepatic cholangiocarcinoma: expert consensus statement. HPB Oxford, 669-680. Xia, J., Ren, Z., Ye, S., Sharma, D., Lin, Z., Gan, Y., . . . Yang, B. (2006). Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. European journal of radiology, 407-412. Yao, F., Bass, N., Nikolai, B., Davern, T., Kerlan, R., Wu, V., . . . Roberts, J. (2002). Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention- to-treat principle and dropout from the waiting list. Liver transplantation: official publication of the American Association for the study of liver disease and the International Liver Transplantation Society, 873-883. Yao, F., Ferrell, L., Bass, N., Watson, J., Bacchetti, P., Venook, A., . . . Roberts, J. (2001). Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology, 1394-1403. Yao, F., Kerlan, R., Hirose, R., Davern, T., Bass, N., Feng, S., . . . Roberts, J. (2008). Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology, 819-827. Zardi, E., Di Matteo, F., Santini, D., Uwechie, V., Crucitti, P., Carassiti, M., . . . Afeltra, A. (2008). Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature. Jurnal of experimental and clinical cancer research, 27-28.